Format

Send to

Choose Destination
Aust J Gen Pract. 2019 Mar;48(3):100-105.

Pharmacogenomics in general practice: The time has come.

Author information

1
BSc, BPharm (Hons), MD, PhD Clinical Pharmacology Registrar, Royal Adelaide Hospital, Port Road, Adelaide, SA; Medical Director of Model Informed Precision Dosing, Certara, Princeton, NJ; Senior Lecturer, Centre for Medicines Use and Safety, Monash University, Parkville, Vic.
2
MBBS, PhD, FRCPA Director of Genetics, Douglass Hanly Moir Pathology, Macquarie Park, NSW; Adjunct Fellow, Department of Biomedical Sciences, Macquarie University, NSW.
3
MBBS, PhD, FRACP, FRCPA, Director of Genetics, Sonic Healthcare, Macquarie Park, NSW; Department of Paediatrics, University of Adelaide, SA.

Abstract

BACKGROUND:

Patients respond to medications differently because of variations in theĀ genes that determine medication exposure and medication response.

OBJECTIVE:

The aim of this review is to introduce pharmacogenomic testing and explain how to start using pharmacogenomic tests in general practice.

DISCUSSION:

Knowledge of the variants in pharmacogenomics is useful when prescribing a variety of medications. International guidelines have identified at least 15 genes for which testing can inform the prescribing of 30 different medications with good evidence of clinical benefit. Nonetheless, pharmacogenomic tests should not be used as the sole basis for prescribing decisions, and should be considered in the context of other relevant clinical and laboratory features. General practitioners can incorporate pharmacogenomic tests into their clinical practice for patients with medication-related problems or those who are likely to require medications for which pharmacogenomics can provide guidance.

PMID:
31256470
Free full text

Supplemental Content

Full text links

Icon for Australian Family Physician
Loading ...
Support Center